Literature DB >> 28980851

Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole.

Yuvraj Dange1, Somnath Bhinge2, Vijay Salunkhe1.   

Abstract

A simple, rapid, and robust RP-HPLC method have been developed and validated to measure palbociclib (PB) and letrozole (LT) at single wavelength (254 nm). A isocratic elution of samples performed on Intersil C8 (4.6 mm × 250 mm particle size 5 μm) column with mobile phase consisting 0.02 M sodium dihydrogen phosphate buffer (pH 5.5): acetonitrile: methanol (80:10:10 v/v/v) delivered at flow rate 1.0 mL min-1. A good linear response was achieved over the range of 5-50 μg mL-1. The LODs for PB and LT were found to be 0.098 and 0.0821 µg mL-1, while the LOQs for PB and LT were 0.381-0.315 µg mL-1, respectively. The method was quantitatively evaluated in terms of system suitability test, linearity, precision, accuracy (recovery) and robustness as per standard guidelines. The method is simple, convenient and suitable for the analysis of PB and LT in bulk drug.

Entities:  

Keywords:  RP-HPLC; letrozole; palbociclib; validation

Mesh:

Substances:

Year:  2017        PMID: 28980851     DOI: 10.1080/15376516.2017.1388458

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  1 in total

1.  Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Authors:  Lu Turković; Luka Bočkor; Oscar Ekpenyong; Tajana Silovski; Mila Lovrić; Slaven Crnković; Biljana Nigović; Miranda Sertić
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.